MORC2 is a phosphorylation-dependent DNA compaction machine

Area of Science:

• Molecular Biology
• Biochemistry
• Genetics

Background:

• The Microrchidia (MORC) family comprises ATPases crucial for higher-order chromatin structure and transcriptional suppression.
• The precise mechanisms underlying MORC-mediated chromatin remodeling remain largely uncharacterized.
• MORC2 mutations are implicated in various cancers and neurological diseases.

Purpose of the Study:

• To elucidate the in vitro mechanisms of chromatin remodeling by the MORC2 protein.
• To investigate the role of MORC2's C-terminal domain (CTD) in DNA binding and ATP hydrolysis.
• To identify regulatory factors controlling MORC2's chromatin remodeling activity.

Main Methods:

• In vitro reconstitution of full-length MORC2 protein.
• Biochemical assays to study DNA binding and structural rearrangements.
• Analysis of ATP hydrolysis and cooperative DNA binding kinetics.
• Investigation of CTD phosphorylation effects on MORC2 function.

Main Results:

• MORC2 exhibits multiple DNA-binding sites that undergo structural changes upon binding.
• The CTD acts as a clamp, locking MORC2 onto DNA, regulated by a phosphate-interacting motif.
• ATP hydrolysis and cooperative DNA binding are modulated by the CTD.
• MORC2 induces ATP hydrolysis-dependent DNA compaction in vitro.
• CTD phosphorylation state critically regulates MORC2-mediated chromatin remodeling.

Conclusions:

• MORC2 functions as a DNA-compacting enzyme through ATP hydrolysis.
• CTD phosphorylation is a key regulatory mechanism for MORC2 activity.
• MORC2 CTD phosphorylation represents a potential therapeutic target for associated diseases.